mesalamine has been researched along with Acute Hypercapnic Respiratory Failure in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, A | 1 |
| Karakurum, A | 1 |
1 other study available for mesalamine and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis.
Topics: Acute Lung Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Lung | 2013 |